Sign in or Sign up

User ID

Password

Remember me - forgot password

 

Sign up or Sign in

Name (in full)

Email address

Password

Confirm Password

 

Nifurtimox

Overview

Nifurtimox is the first compound that proved effective in human therapy of the South American trypanosomiasis caused by Trypanosoma cruzi. Chemically itidentified as 3-methyl-N-[(5-niro-2-furanyl) methylene]-4-thiomorpholinamine-1, 2-dioxide. Nifurtimox is tripanocidal against both amastigote and tripomasigote form of Trypanosoma cruzi. iteffective against both acute as well as chronic phase of infection. it is prepared by chemical synthesis. itadministerd orally.

Category:

Primary Characterstics

Molecular Structure of Nifurtimox
. It is of Synthetic origin and belongs to Nitrofurane. It belongs to Antiparasitic pharmacological group on the basis of mechanism of action. The Molecular Weight of Nifurtimox is 287.30.

Pharmacokinetics

Indications

Nifurtimox is primarily indicated in conditions like Leishmaniasis, Onchoceriasis, Trypanosomiasis.

Contraindications

Nifurtimox is contraindicated in conditions like Convulsions,Cerebral impairment.

Drug Interactions

No data regarding the interactions of Nifurtimox was found.

Interference in Pathology

No data regarding the pathological interferences produced by Nifurtimox is available.

Side Effects

The severe or irreversible adverse effects of Nifurtimox, which give rise to further complications include Convulsions, Insomnia, Psychosis, Disorientation, Disturbance of equilibrium.

Nifurtimox produces potentially life-threatening effects which include Leucopenia. which are responsible for the discontinuation of Nifurtimox therapy.

The symptomatic adverse reactions produced by Nifurtimox are more or less tolerable and if they become severe, they can be treated symptomatically, these include Anorexia, Myalgia, Urticaria, Paresthesias, Neuralgia, Morbiliform, Exanthema.

Available Brands

No Brands Available.

Dosage

Nifurtimox's dosage details are as follows:
Dose Single Dose Frequency Route Instructions

Adult Dosage

8 to 10 mg/kg9 (9)24 hourlyPO-

Paedriatic Dosage ( 20 Kg. )

No data regarding the Paedriatic dosage details of Nifurtimox is available.

Neonatal Dosage ( 3 Kg. )

No data regarding the neonatal dosage details of Nifurtimox is available.

High Risk Groups

Drug should not be given to patients suffering from Kidney dysfunction, and Pregnant Mothers.

If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Warning / Precautions

The drug should be used with extreme caution in the pregnant or the breast feeding women and children <1year old.

Storage Conditions

comments powered by Disqus